Status:
TERMINATED
Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease
Lead Sponsor:
EMD Serono
Conditions:
Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and efficacy of interferon beta-1a in maintaining remission in patients with Crohn's disease.
Eligibility Criteria
Inclusion
- Patients with an established diagnosis of Crohn's disease who went into remission using corticosteroids within 4 weeks before the study
Exclusion
- Any other treatment for the maintenance of remission of Crohn's disease
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
End Date :
September 1 2003
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00304252
Start Date
November 1 2001
End Date
September 1 2003
Last Update
August 6 2013
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Information Office
Munich, Germany
2
Medical Information Office
Roma, Italy
3
Medical Information Office
Solna, Sweden
4
Medical Information Office
Zug, Switzerland